Paul L Reiter1, Noel T Brewer, Melissa B Gilkey, Mira L Katz, Electra D Paskett, Jennifer S Smith. 1. Division of Cancer Prevention and Control, College of Medicine, The Ohio State University, Columbus, Ohio; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio; College of Public Health, The Ohio State University, Columbus, Ohio.
Abstract
BACKGROUND: Human papillomavirus (HPV) infection is common among Hispanic males, but to the authors' knowledge little is known regarding HPV vaccination in this population. The authors examined the early adoption of the HPV vaccine among a national sample of Hispanic adolescent males. METHODS: The authors analyzed provider-verified HPV vaccination data from the 2010 through 2012 National Immunization Survey-Teen (NIS-Teen) for Hispanic males aged 13 years to 17 years (n = 4238). Weighted logistic regression identified correlates of HPV vaccine initiation (receipt of ≥ 1 doses). RESULTS: HPV vaccine initiation was 17.1% overall, increasing from 2.8% in 2010 to 31.7% in 2012 (P < .0001). Initiation was higher among sons whose parents had received a provider recommendation to vaccinate compared with those whose parents had not (53.3% vs 9.0%; odds ratio, 8.77 [95% confidence interval, 6.05-12.70]). Initiation was also higher among sons who had visited a health care provider within the previous year (odds ratio, 2.42; 95% confidence interval, 1.39-4.23). Among parents with unvaccinated sons, Spanish-speaking parents reported much higher intent to vaccinate compared with English-speaking parents (means: 3.52 vs 2.54; P < .0001). Spanish-speaking parents were more likely to indicate lack of knowledge (32.9% vs 19.9%) and not having received a provider recommendation (32.2% vs 17.7%) as the main reasons for not intending to vaccinate (both P < .05). CONCLUSIONS: HPV vaccination among Hispanic adolescent males has increased substantially in recent years. Ensuring health care visits and provider recommendation will be key for continuing this trend. Preferred language may also be important for increasing HPV vaccination and addressing potential barriers to vaccination.
BACKGROUND:Humanpapillomavirus (HPV) infection is common among Hispanic males, but to the authors' knowledge little is known regarding HPV vaccination in this population. The authors examined the early adoption of the HPV vaccine among a national sample of Hispanic adolescent males. METHODS: The authors analyzed provider-verified HPV vaccination data from the 2010 through 2012 National Immunization Survey-Teen (NIS-Teen) for Hispanic males aged 13 years to 17 years (n = 4238). Weighted logistic regression identified correlates of HPV vaccine initiation (receipt of ≥ 1 doses). RESULTS:HPV vaccine initiation was 17.1% overall, increasing from 2.8% in 2010 to 31.7% in 2012 (P < .0001). Initiation was higher among sons whose parents had received a provider recommendation to vaccinate compared with those whose parents had not (53.3% vs 9.0%; odds ratio, 8.77 [95% confidence interval, 6.05-12.70]). Initiation was also higher among sons who had visited a health care provider within the previous year (odds ratio, 2.42; 95% confidence interval, 1.39-4.23). Among parents with unvaccinated sons, Spanish-speaking parents reported much higher intent to vaccinate compared with English-speaking parents (means: 3.52 vs 2.54; P < .0001). Spanish-speaking parents were more likely to indicate lack of knowledge (32.9% vs 19.9%) and not having received a provider recommendation (32.2% vs 17.7%) as the main reasons for not intending to vaccinate (both P < .05). CONCLUSIONS:HPV vaccination among Hispanic adolescent males has increased substantially in recent years. Ensuring health care visits and provider recommendation will be key for continuing this trend. Preferred language may also be important for increasing HPV vaccination and addressing potential barriers to vaccination.
Authors: Paul L Reiter; Kunal Gupta; Noel T Brewer; Melissa B Gilkey; Mira L Katz; Electra D Paskett; Jennifer S Smith Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-03-14 Impact factor: 4.254
Authors: Alan Nyitray; Carrie M Nielson; Robin B Harris; Roberto Flores; Martha Abrahamsen; Eileen F Dunne; Anna R Giuliano Journal: J Infect Dis Date: 2008-06-15 Impact factor: 5.226
Authors: Carrie M Nielson; Robin B Harris; Roberto Flores; Martha Abrahamsen; Mary R Papenfuss; Eileen F Dunne; Lauri E Markowitz; Anna R Giuliano Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-03-24 Impact factor: 4.254
Authors: Luisa A Watts; Naima Joseph; Maria Wallace; Jose A Rauh-Hain; Alona Muzikansky; Whitfield B Growdon; Marcela G del Carmen Journal: Gynecol Oncol Date: 2009-01-15 Impact factor: 5.482
Authors: Angelica M Roncancio; Sally W Vernon; Chakema C Carmack; Kristy K Ward; Becky T Muñoz; Felicity L Cribbs Journal: J Immigr Minor Health Date: 2019-12
Authors: Angelica M Roncancio; Chakema C Carmack; Kristy K Ward; Sally W Vernon; Becky T Muñoz; Miguel A Cano; Felicity L Cribbs Journal: Fam Community Health Date: 2019 Apr/Jun
Authors: Abbey B Berenson; Mahbubur Rahman; Jacqueline M Hirth; Richard E Rupp; Kwabena O Sarpong Journal: Hum Vaccin Immunother Date: 2015 Impact factor: 3.452
Authors: Kate E Dibble; Jessica L Maksut; Elizabeth J Siembida; Morica Hutchison; Keith M Bellizzi Journal: J Adolesc Young Adult Oncol Date: 2019-05-15 Impact factor: 2.223
Authors: Peng-Jun Lu; David Yankey; Jenny Jeyarajah; Alissa O'Halloran; Laurie D Elam-Evans; Philip J Smith; Shannon Stokley; James A Singleton; Eileen F Dunne Journal: Pediatrics Date: 2015-11 Impact factor: 7.124
Authors: Angelica M Roncancio; Chakema C Carmack; Veronica Garcia-Morales; Felicity L Cribbs; Miguel A Cano Journal: Ethn Health Date: 2018-08-24 Impact factor: 2.772